NextGen Omics 2023

Published on : Published by : Chris Frew

Join leaders, experts and researchers at the most scientifically engaging event in London delivering breakthrough research, technologies and therapeutic applications across Next Generation Sequencing, Clinical Diagnostics, Single Cell & Spatial [….]

Scientific Industries Announces Appointment of Dr. Jürgen Schumacher to the Board of Directors

Published on : Published by : BioBuzz Media

Dr. Jürgen Schumacher is an internationally recognized German entrepreneur with more than 35 years of expertise in the biotech industry. Dr. Schumacher co-founded Qiagen AG, one of Germany’s largest biotechnology companies, NewLab Bioquality AG, which was acquired by Charles River Laboratories International Inc., BiBiTech and Algiax Pharmaceuticals. Dr. Schumacher advises and invests in promising biotech business models.

5 Questions with Mark Nardone, PMP, Director, Bio-Trac®

Published on : Published by : Andy Eckert

Mark Nardone is Director and Co-Founder of Bio-Trac®, a biotechnology training program that has served the scientific community for over 37 years, providing hands-on training workshops, designed by active researchers for research scientists, that focus on the latest relevant techniques that are necessary for laboratory research.

5 Questions with Ian Sarad, BioProcess Application Engineer, Scientific Bioprocessing

Published on : Published by : Andy Eckert

Ian is an industrial microbiologist and fermentation scientist specializing in process optimization and upstream modification of cell culture parameters for increased yield, viability, and productivity. Experienced with a variety of fermentation technologies, including hollow-fiber bioreactor systems, industrial stirred-tanks, and shake-flasks, Ian is excited to lend his background in cell culture to the SBI team.

Maryland Startup Apsis Healthcare Systems Striving to Simplify Drug Development Where Technology and Biology Meet

Published on : Published by : Steven Surdez

University of Maryland alumni, Sathya Janardhanan, founded Apsis Healthcare Systems in 2018 to help biotech and pharma companies of all sizes simplify drug development through process automation and leveraging the power of Big Data.